|
| Immune evasion mechanisms of arenaviruses |
|
https://doi.org/10.18632/oncotarget.6367
Hinh Ly, and Yuying Liang
|
| 40386-40387 |
|
| A new class of small molecule estrogen receptoralpha antagonists that overcome antiestrogen resistance |
|
https://doi.org/10.18632/oncotarget.6323
Yongxian Ma, Anju Preet, York Tomita, Eliseu De Oliveira, Li Zhang, Yumi Ueda, Robert Clarke, Milton Brown, and Eliot M. Rosen
|
| 40388-40404 |
|
| Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras |
|
https://doi.org/10.18632/oncotarget.6334
Suhyun Sung, Jungwon Choi, and Heesun Cheong
|
| 40405-40417 |
|
| Genomic binding and regulation of gene expression by the thyroid carcinomaassociated PAX8PPARG fusion protein |
|
https://doi.org/10.18632/oncotarget.6340
Yanxiao Zhang, Jingcheng Yu, Chee Lee, Bin Xu, Maureen A. Sartor, and Ronald J. Koenig
|
| 40418-40432 |
|
| In vivo regeneration of renal vessels post whole decellularized kidneys transplantation |
|
https://doi.org/10.18632/oncotarget.6321
JianSe Zhang, ZhiBin Wang, KeZhi Lin, YaLing Yu, LiNa Zhao, TingGang Chu, LiZhi Wu, Ali Alkhawaji, MiaoZhong Li, YingKuan Shao, Ting Li, XinFa Lou, ShiXin Chen, MaoLin Tang, and Jin Mei
|
| 40433-40442 |
|
| Linking estrogen receptor β expression with inflammatory bowel disease activity |
|
https://doi.org/10.18632/oncotarget.6217
Marina Pierdominici, Angela Maselli, Barbara Varano, Cristiana Barbati, Paola Cesaro, Cristiano Spada, Angelo Zullo, Roberto Lorenzetti, Marco Rosati, Gabriella Rainaldi, Maria Rosaria Limiti, Luisa Guidi, Lucia Conti, and Sandra Gessani
|
| 40443-40451 |
|
| Myelin oligodendrocyte glycoprotein MOG3555induced experimental autoimmune encephalomyelitis is ameliorated in interleukin32 alpha transgenic mice |
|
https://doi.org/10.18632/oncotarget.6306
Jaesuk Yun, Sun Mi Gu, Hyung Mun Yun, Dong Ju Son, Mi Hee Park, Moon Soon Lee, and Jin Tae Hong
|
| 40452-40463 |
|
| Interaction of RECQ4 and MCM10 is important for efficient DNA replication origin firing in human cells |
|
https://doi.org/10.18632/oncotarget.6342
Maciej Kliszczak, Hana Sedlackova, Ganesha P. Pitchai, Werner W. Streicher, Lumir Krejci, and Ian D. Hickson
|
| 40464-40479 |
|
| Deconvoluting the complexity of autophagy and Parkinson’s disease for potential therapeutic purpose |
|
https://doi.org/10.18632/oncotarget.5803
Jingjing Li, Sijia Li, Lan Zhang, Liang Ouyang, and Bo Liu
|
| 40480-40495 |
|
| Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction |
|
https://doi.org/10.18632/oncotarget.5800
Reinaldo Franqui-Machin, Erik B. Wendlandt, Siegfried Janz, Fenghuang Zhan, and Guido Tricot
|
| 40496-40506 |
|
| Vascular heterogeneity and targeting: the role of YKL40 in glioblastoma vascularization |
|
https://doi.org/10.18632/oncotarget.5943
Rong Shao, Sherry L. Taylor, Dennis S. Oh, and Lawrence M. Schwartz
|
| 40507-40518 |
|
| Identification of shortform RON as a novel intrinsic resistance mechanism for antiMET therapy in METpositive gastric cancer |
|
https://doi.org/10.18632/oncotarget.5816
Zheng Wu, Zhe Zhang, Xiaoxiao Ge, Ying Lin, Congqi Dai, Jinjia Chang, Xinyang Liu, Ruixuan Geng, Chenchen Wang, Huan Chen, Menghong Sun, Weijian Guo, and Jin Li
|
| 40519-40534 |
|
| Overexpression of Mcl1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma |
|
https://doi.org/10.18632/oncotarget.5755
Neel M. Fofaria, Dennie T. Frederick, Ryan J. Sullivan, Keith T. Flaherty, and Sanjay K. Srivastava
|
| 40535-40556 |
|
| Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA |
|
https://doi.org/10.18632/oncotarget.5829
Marco Perez, Sandra Muñoz-Galván, Manuel P. Jiménez-GarcÃa, Juan J. MarÃn, and Amancio Carnero
|
| 40557-40574 |
|
| Exosomes enriched in stemness/metastaticrelated mRNAS promote oncogenic potential in breast cancer |
|
https://doi.org/10.18632/oncotarget.5818
Marta RodrÃguez, Javier Silva, Alberto Herrera, Mercedes Herrera, Cristina Peña, Paloma MartÃn, Beatriz Gil-Calderón, MarÃa Jesús Larriba, Mª José Coronado, Beatriz Soldevilla, VÃctor S. Turrión, Mariano Provencio, Antonio Sánchez, Félix Bonilla, and Vanesa GarcÃa-Barberán
|
| 40575-40587 |
|
| Wholeexome sequencing and genomewide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome |
|
https://doi.org/10.18632/oncotarget.5845
Christen Lykkegaard Andersen, Helene Myrtue Nielsen, Lasse Sommer Kristensen, Alexandra Søgaard, Jonas Vikeså, Lars Jønson, Finn Cilius Nielsen, Hans Hasselbalch, Ole Weis Bjerrum, Vasu Punj, and Kirsten Grønbæk
|
| 40588-40597 |
|
| Novel C6substituted 134oxadiazinones as potential anticancer agents |
|
https://doi.org/10.18632/oncotarget.5839
Maqusood Md. Alam, Su-Chan Lee, Yujin Jung, Hye Jeong Yun, Hye-Young Min, Ho Jin Lee, Phuong Chi Pham, Jayoung Moon, Dah In Kwon, Bumhee Lim, Young-Ger Suh, Jeeyeon Lee, and Ho-Young Lee
|
| 40598-40610 |
|
| Identification of specific DNA methylation sites on the Ychromosome as biomarker in prostate cancer |
|
https://doi.org/10.18632/oncotarget.6141
Lushuai Yao, Shancheng Ren, Minjie Zhang, Fengxia Du, Yasheng Zhu, Hui Yu, Chenyu Zhang, Xiaohua Li, Caiyun Yang, Huixian Liu, Dong Wang, Hao Meng, Shuang Chang, Xiao Han, Yinghao Sun, and Yingli Sun
|
| 40611-40621 |
|
| Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5872
Xiong Lei, Yun-feng Li, Guo-dong Chen, Di-peng Ou, Xiao-xin Qiu, Chao-hui Zuo, and Lian-Yue Yang
|
| 40622-40641 |
|
| Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine |
|
https://doi.org/10.18632/oncotarget.5841
Vivek Subbiah, Michael J. Wagner, Mary F. McGuire, Nawid M. Sarwari, Eswaran Devarajan, Valerae O. Lewis, Shanon Westin, Shumei Kato, Robert E. Brown, and Pete Anderson
|
| 40642-40654 |
|
| Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2 |
|
https://doi.org/10.18632/oncotarget.5821
Daibiao Xiao, Ping Ren, Hexiu Su, Ming Yue, Ruijuan Xiu, Yufeng Hu, Hudan Liu, and Guoliang Qing
|
| 40655-40666 |
|
| Doxycycline reverses epithelialtomesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells |
|
https://doi.org/10.18632/oncotarget.5842
Yuan Qin, Qiang Zhang, Shan Lee, Wei-long Zhong, Yan-rong Liu, Hui-juan Liu, Dong Zhao, Shuang Chen, Ting Xiao, Jing Meng, Xue-shuang Jing, Jing Wang, Bo Sun, Ting-ting Dai, Cheng Yang, Tao Sun, and Hong-gang Zhou
|
| 40667-40679 |
|
| Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alphafetoprotein in vitro and in vivo involving the NFkappaB and the betacatenin pathways |
|
https://doi.org/10.18632/oncotarget.5673
Nicola Bortel, Sorin Armeanu-Ebinger, Evi Schmid, Bettina Kirchner, Jan Frank, Alexa Kocher, Christina Schiborr, Steven Warmann, Jörg Fuchs, and Verena Ellerkamp
|
| 40680-40691 |
|
| A novel chemical STF083010 reverses tamoxifenrelated drug resistance in breast cancer by inhibiting IRE1/XBP1 |
|
https://doi.org/10.18632/oncotarget.5827
Jie Ming, Shengnan Ruan, Mengyi Wang, Dan Ye, Ningning Fan, Qingyu Meng, Bo Tian, and Tao Huang
|
| 40692-40703 |
|
| UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression |
|
https://doi.org/10.18632/oncotarget.5727
Sajjad Hussain, Tibor Bedekovics, Marta Chesi, P. Leif Bergsagel, and Paul J. Galardy
|
| 40704-40718 |
|
| Interleukin 6 trigged ataxiatelangiectasia mutated activation facilitates lung cancer metastasis via MMP3/MMP13 upregulation |
|
https://doi.org/10.18632/oncotarget.5825
Yi Na Jiang, Hong Qiong Yan, Xiao Bo Huang, Yi Nan Wang, Qing Li, and Feng Guang Gao
|
| 40719-40733 |
|
| Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells |
|
https://doi.org/10.18632/oncotarget.5754
Sanjay Kumar, and Paul B. Tchounwou
|
| 40734-40746 |
|
| IL32θ gene expression in acute myeloid leukemia suppresses TNFα production |
|
https://doi.org/10.18632/oncotarget.5688
Man Sub Kim, Jeong-Woo Kang, Jae-Sik Jeon, Jae Kyung Kim, Jong Wan Kim, Jintae Hong, and Do-Young Yoon
|
| 40747-40761 |
|
| A biotherapy based on PSCsin3D spheroidameliorated biologics depletes in vivo cancersustaining stem cells |
|
https://doi.org/10.18632/oncotarget.5691
Wenhui Zhang, Huanhuan Yang, Yanna Zhang, Yanan Lu, Tianlin Zhou, Meng Li, Yanjun Wen, Xiaojuan Lin, Rong Xiang, and Xiancheng Chen
|
| 40762-40774 |
|
| CUDR promotes liver cancer stem cell growth through upregulating TERT and CMyc |
|
https://doi.org/10.18632/oncotarget.5805
Hu Pu, Qidi Zheng, Haiyan Li, Mengying Wu, Jiahui An, Xin Gui, Tianming Li, and Dongdong Lu
|
| 40775-40798 |
|
| MicroRNA29B mir29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3 |
|
https://doi.org/10.18632/oncotarget.5695
Yue Teng, Yan Zhang, Kai Qu, Xinyuan Yang, Jing Fu, Wei Chen, and Xu Li
|
| 40799-40814 |
|
| A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patientderived xenograft than KRAS 12/13 mutations |
|
https://doi.org/10.18632/oncotarget.5886
Dawei Chen, Xuesong Huang, Jie Cai, Sheng Guo, Wubin Qian, Jean-Pierre Wery, and Qi-Xiang Li
|
| 40815-40821 |
|
| Active glycolytic metabolism in CD133+ hepatocellular cancer stem cells: regulation by MIR122 |
|
https://doi.org/10.18632/oncotarget.5812
Kyoungsub Song, Hyunjoo Kwon, Chang Han, Jinqiang Zhang, Srikanta Dash, Kyu Lim, and Tong Wu
|
| 40822-40835 |
|
| Distribution and prognostic relevance of tumorinfiltrating lymphocytes TILs and PD1/PDL1 immune checkpoints in human brain metastases |
|
https://doi.org/10.18632/oncotarget.5696
Patrick N. Harter, Simon Bernatz, Alexander Scholz, Pia S. Zeiner, Jenny Zinke, Makoto Kiyose, Stella Blasel, Rudi Beschorner, Christian Senft, Benjamin Bender, Michael W. Ronellenfitsch, Harriet Wikman, Markus Glatzel, Matthias Meinhardt, Tareq A. Juratli, Joachim P. Steinbach, Karl H. Plate, Jörg Wischhusen, Benjamin Weide, and Michel Mittelbronn
|
| 40836-40849 |
|
| Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/Pglycoproteinoverexpressing cancer cells |
|
https://doi.org/10.18632/oncotarget.5813
Fang Wang, Yifan Chen, Lihua Huang, Tao Liu, Yue Huang, Jianming Zhao, Xiaokun Wang, Ke Yang, Shaolin Ma, Liyan Huang, Kenneth Kin Wah To, Yong Gu, and Liwu Fu
|
| 40850-40865 |
|
| Biscyclopropane analog of disorazole C1 is a microtubuledestabilizing agent active in ABCB1overexpressing human colon cancer cells |
|
https://doi.org/10.18632/oncotarget.5885
Shaoyu Wu, Zhijian Guo, Chad D. Hopkins, Ning Wei, Edward Chu, Peter Wipf, and John C. Schmitz
|
| 40866-40879 |
|
| Amphiregulin enhances intercellular adhesion molecule1 expression and promotes tumor metastasis in human osteosarcoma |
|
https://doi.org/10.18632/oncotarget.5679
Ju-Fang Liu, Ya-Ting Tsao, and Chun-Han Hou
|
| 40880-40895 |
|
| IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry |
|
https://doi.org/10.18632/oncotarget.5683
Pei Yang, Wei Zhang, Yinyan Wang, Xiaoxia Peng, Baoshi Chen, Xiaoguang Qiu, Guilin Li, Shouwei Li, Chenxing Wu, Kun Yao, Wenbin Li, Wei Yan, Jie Li, Yongping You, Clark C. Chen, and Tao Jiang
|
| 40896-40906 |
|
| Disulfiram inhibits TGFβinduced epithelialmesenchymal transition and stemlike features in breast cancer via ERK/NFκB/Snail pathway |
|
https://doi.org/10.18632/oncotarget.5723
Dan Han, Gang Wu, Chan Chang, Fang Zhu, Yin Xiao, Qiuhui Li, Tao Zhang, and Liling Zhang
|
| 40907-40919 |
|
| Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5712
Xiao-Fei Zhang, Jie Chao, Qiu-Zhong Pan, Ke Pan, De-Sheng Weng, Qi-Jing Wang, Jing-Jing Zhao, Jia He, Qing Liu, Shan-Shan Jiang, Chang-Long Chen, Hong-Xia Zhang, and Jian-Chuan Xia
|
| 40920-40933 |
|
| Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney |
|
https://doi.org/10.18632/oncotarget.5882
Annalisa Astolfi, Fraia Melchionda, Daniela Perotti, Maura Fois, Valentina Indio, Milena Urbini, Chiara Giusy Genovese, Paola Collini, Nunzio Salfi, Marilina Nantron, Paolo D’Angelo, Filippo Spreafico, and Andrea Pession
|
| 40934-40939 |
|
| Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5724
Cheng-Rong Xie, Zhao Li, Hong-Guang Sun, Fu-Qiang Wang, Yu Sun, Wen-Xiu Zhao, Sheng Zhang, Wen-Xing Zhao, Xiao-Min Wang, and Zhen-Yu Yin
|
| 40940-40952 |
|
| ÂÂPrevalence of deleterious ATM germline mutations in gastric cancer patients |
|
https://doi.org/10.18632/oncotarget.5944
Dong-Sheng Huang, Hou-Quan Tao, Xu-Jun He, Ming Long, Sheng Yu, Ying-Jie Xia, Zhang Wei, Zikai Xiong, Sian Jones, Yiping He, Hai Yan, and Xiaoyue Wang
|
| 40953-40958 |
|
| PTTG regulates the metabolic switch of ovarian cancer cells via the cmyc pathway |
|
https://doi.org/10.18632/oncotarget.5726
Xiu Wang, Wanxing Duan, Xuqi Li, Jiangbo Liu, Donghong Li, Lianhong Ye, Lu Qian, Aijun Yang, Qinhong Xu, Han Liu, Qiaoshan Fu, Erxi Wu, Qingyong Ma, and Xin Shen
|
| 40959-40969 |
|
| Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin |
|
https://doi.org/10.18632/oncotarget.5403
Maria Claudia Vladoiu, Marilyne Labrie, Myriam Létourneau, Philippe Egesborg, Donald Gagné, Étienne Billard, Andrée-Anne Grosset, Nicolas Doucet, David Chatenet, and Yves St-Pierre
|
| 40970-40980 |
|
| The Hsp90 inhibitor SNX7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human p53negative chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.5715
Kimberley L. Kaufman, Yiping Jenkins, Munther Alomari, Mehdi Mirzaei, O.Giles Best, Dana Pascovici, Swetlana Mactier, Stephen P. Mulligan, Paul A. A. Haynes, and Richard I. Christopherson
|
| 40981-40997 |
|
| Heterogeneous glioblastoma cell crosstalk promotes phenotype alterations and enhanced drug resistance |
|
https://doi.org/10.18632/oncotarget.5701
Helena Motaln, Ana Koren, Kristina Gruden, Živa Ramšak, Christian Schichor, and Tamara T. Lah
|
| 40998-41017 |
|
| Anticancer efficacy of SREBP inhibitor alone or in combination with docetaxel in prostate cancer harboring p53 mutations |
|
https://doi.org/10.18632/oncotarget.5879
Xiangyan Li, Jason Boyang Wu, Leland W.K. Chung, and Wen-Chin Huang
|
| 41018-41032 |
|
| The copy number of EpsteinBarr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NFκB |
|
https://doi.org/10.18632/oncotarget.5708
Lielian Zuo, Haibo Yu, Lingzhi Liu, Yunlian Tang, Hongzhuan Wu, Jing Yang, Meijuan Zhu, Shujuan Du, Lian Zhao, Li Cao, Guiyuan Li, and Jianhong Lu
|
| 41033-41044 |
|
| LncRNA MALAT1 enhances oncogenic activities of EZH2 in castrationresistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.5728
Dejie Wang, Liya Ding, Liguo Wang, Yu Zhao, Zhifu Sun, R.Jeffrey Karnes, Jun Zhang, and Haojie Huang
|
| 41045-41055 |
|
| YpT12N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT12N0 rectal cancer |
|
https://doi.org/10.18632/oncotarget.5379
Jue-feng Wan, Ji Zhu, Gui-chao Li, Wen-jie Sun, and Zhen Zhang
|
| 41056-41062 |
|
| Inhibition of Eph receptor A4 by 25dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice |
|
https://doi.org/10.18632/oncotarget.5729
Hironobu Takano, Toru Nakamura, Takahiro Tsuchikawa, Toshihiro Kushibiki, Kouji Hontani, Kazuho Inoko, Mizuna Takahashi, Shoki Sato, Hirotake Abe, Shintaro Takeuchi, Nagato Sato, Kei Hiraoka, Hiroshi Nishihara, Toshiaki Shichinohe, and Satoshi Hirano
|
| 41063-41076 |
|
| Epigenetic downregulation of the ISG15–conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.6218
Xiaoying Zhou, Jiazhang Wei, Fu Chen, Xue Xiao, Tingting Huang, Qian He, Shumin Wang, Chunping Du, Yingxi Mo, Longde Lin, Ying Xie, Lili Wei, Ying Lan, Mairiko Murata, Guangwu Huang, Ingemar Ernberg, Liudmila Matskova, and Zhe Zhang
|
| 41077-41091 |
|
| CMTM7 knockdown increases tumorigenicity of human nonsmall cell lung cancer cells and EGFRAKT signaling by reducing Rab5 activation |
|
https://doi.org/10.18632/oncotarget.5732
Baocai Liu, Yu Su, Ting Li, Wanqiong Yuan, Xiaoning Mo, Henan Li, Qihua He, Dalong Ma, and Wenling Han
|
| 41092-41107 |
|
| Germline variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients |
|
https://doi.org/10.18632/oncotarget.5694
Balazs Jóri, Rick Kamps, Sofia Xanthoulea, Bert Delvoux, Marinus J. Blok, Koen K. Van de Vijver, Bart de Koning, Felicia Trups Oei, Carli M. Tops, Ernst J. M. Speel, Roy F. Kruitwagen, Encarna B. Gomez-Garcia, and Andrea Romano
|
| 41108-41122 |
|
| Chemical probing of HER2amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib |
|
https://doi.org/10.18632/oncotarget.5660
Dhara N. Amin, Ana Ruiz-Saenz, Nathaniel Gulizia, and Mark M. Moasser
|
| 41123-41133 |
|
| Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptorpositive invasive ductal breast carcinoma |
|
https://doi.org/10.18632/oncotarget.5838
Arvydas Laurinavicius, Andrew R. Green, Aida Laurinaviciene, Giedre Smailyte, Valerijus Ostapenko, Raimundas Meskauskas, and Ian O. Ellis
|
| 41134-41145 |
|
| Silibininmediated metabolic reprogramming attenuates pancreatic cancerinduced cachexia and tumor growth |
|
https://doi.org/10.18632/oncotarget.5843
Surendra K. Shukla, Aneesha Dasgupta, Kamiya Mehla, Venugopal Gunda, Enza Vernucci, Joshua Souchek, Gennifer Goode, Ryan King, Anusha Mishra, Ibha Rai, Sangeetha Nagarajan, Nina V. Chaika, Fang Yu, and Pankaj K. Singh
|
| 41146-41161 |
|
| P2X3 purinergic receptor overexpression is associated with poor recurrencefree survival in hepatocellular carcinoma patients |
|
https://doi.org/10.18632/oncotarget.6240
Janielle P. Maynard, Ju-Seog Lee, Bo Hwa Sohn, Xiaoying Yu, Dolores Lopez-Terrada, Milton J. Finegold, John A. Goss, and Sundararajah Thevananther
|
| 41162-41179 |
|
| Isothiocyanatostilbenes as novel cMet inhibitors |
|
https://doi.org/10.18632/oncotarget.5748
Alana L. Gray, David T. Coleman, Reneau F. Castore, Mohamed M. Mohyeldin, Khalid A. El Sayed, and James A. Cardelli
|
| 41180-41193 |
|
| Tetracyclineinducible shRNA targeting long noncoding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells |
|
https://doi.org/10.18632/oncotarget.5880
Chengle Zhuang, Jianfa Li, Yuchen Liu, Mingwei Chen, Jiancheng Yuan, Xing Fu, Yonghao Zhan, Li Liu, Junhao Lin, Qing Zhou, Wen Xu, Guoping Zhao, Zhiming Cai, and Weiren Huang
|
| 41194-41203 |
|
| Morphometric analysis of immunoselection against hyperploid cancer cells |
|
https://doi.org/10.18632/oncotarget.5400
Norma Bloy, Allan Sauvat, Kariman Chaba, Aitziber Buqué, Juliette Humeau, José Manuel Bravo-San Pedro, Jack Bui, Oliver Kepp, Guido Kroemer, and Laura Senovilla
|
| 41204-41215 |
|
| Identifying clinically relevant drug resistance genes in druginduced resistant cancer cell lines and postchemotherapy tissues |
|
https://doi.org/10.18632/oncotarget.5649
Mengsha Tong, Weicheng Zheng, Xingrong Lu, Lu Ao, Xiangyu Li, Qingzhou Guan, Hao Cai, Mengyao Li, Haidan Yan, You Guo, Pan Chi, and Zheng Guo
|
| 41216-41227 |
|
| Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.5682
Liang Wang, Hua Wang, Hao Chen, Wei-da Wang, Xiao-qin Chen, Qi-rong Geng, Zhong-jun Xia, and Yue Lu
|
| 41228-41236 |
|
| Novel insights into Notum and glypicans regulation in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.5652
Mariangela De Robertis, Maddalena Arigoni, Luisa Loiacono, Federica Riccardo, Raffaele Adolfo Calogero, Yana Feodorova, Dessislava Tashkova, Vesselin Belovejdov, Victoria Sarafian, Federica Cavallo, and Emanuela Signori
|
| 41237-41257 |
|
| Peptide mediated active targeting and intelligent particle size reductionmediated enhanced penetrating of fabricated nanoparticles for triplenegative breast cancer treatment |
|
https://doi.org/10.18632/oncotarget.5692
Guanlian Hu, Xingli Chun, Yang Wang, Qin He, and Huile Gao
|
| 41258-41274 |
|
| Junctional adhesion moleculeA is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus |
|
https://doi.org/10.18632/oncotarget.5753
Kevin R. Kelly, Claudia M. Espitia, Weiguo Zhao, Erik Wendlandt, Guido Tricot, Fenghuang Zhan, Jennifer S. Carew, and Steffan T. Nawrocki
|
| 41275-41289 |
|
| TIP60miR22 axis as a prognostic marker of breast cancer progression |
|
https://doi.org/10.18632/oncotarget.5636
Amit Kumar Pandey, Yanzhou Zhang, Siting Zhang, Ying Li, Greg Tucker-Kellogg, Henry Yang, and Sudhakar Jha
|
| 41290-41306 |
|
| E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling |
|
https://doi.org/10.18632/oncotarget.5846
Sharon McGonigle, Zhihong Chen, Jiayi Wu, Paul Chang, Donna Kolber-Simonds, Karen Ackermann, Natalie C. Twine, Jue-lon Shie, Jingzang Tao Miu, Kuan-Chun Huang, George A. Moniz, and Kenichi Nomoto
|
| 41307-41323 |
|
| Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase8/TRAF2mediated signaling |
|
https://doi.org/10.18632/oncotarget.5847
You-Take Oh, Ping Yue, Dongsheng Wang, Jing-Shan Tong, Zhuo G. Chen, Fadlo R. Khuri, and Shi-Yong Sun
|
| 41324-41338 |
|
| A phase I clinical trial utilizing autologous tumorinfiltrating lymphocytes in patients with primary hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5463
Shan-Shan Jiang, Yan Tang, Yao-Jun Zhang, De-Sheng Weng, Zhong-Guo Zhou, Ke Pan, Qiu-Zhong Pan, Qi-Jing Wang, Qing Liu, Jia He, Jing-Jing Zhao, Jiang Li, Min-Shan Chen, Alfred E. Chang, Qiao Li, and Jian-Chuan Xia
|
| 41339-41349 |
|
| The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cellscytokine induced killer cells infusion |
|
https://doi.org/10.18632/oncotarget.5534
Qing-Kun Song, Jun Ren, Xin-Na Zhou, Xiao-Li Wang, Guo-Hong Song, Li-Jun Di, Jing Yu, Amy Hobeika, Michael A. Morse, Yan-Hua Yuan, Hua-Bing Yang, and Herbert Kim Lyerly
|
| 41350-41359 |
|
| ALDH1A1 mRNA expression in association with prognosis of triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.6023
Yan Liu, Michelle Baglia, Ying Zheng, William Blot, Ping-Ping Bao, Hui Cai, Sarah Nechuta, Wei Zheng, Qiuyin Cai, and Xiao Ou Shu
|
| 41360-41369 |
|
| Prognostic significance of the combination of preoperative hemoglobin albumin lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study |
|
https://doi.org/10.18632/oncotarget.5629
Xiao-Long Chen, Lian Xue, Wei Wang, Hai-Ning Chen, Wei-Han Zhang, Kai Liu, Xin-Zu Chen, Kun Yang, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, and Jian-Kun Hu
|
| 41370-41382 |
|
| A novel prognostic biomarker SPC24 upregulated in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5510
Pengpeng Zhu, Junfei Jin, Yan Liao, Jun Li, Xue-Zhong Yu, Weijia Liao, and Songqing He
|
| 41383-41397 |
|
| Erratum: Bisphosphonateinduced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclastmediated NK cell activation |
|
https://doi.org/10.18632/oncotarget.6431
Han-Ching Tseng, Keiichi Kanayama, Kawaljit Kaur, So-Hyun Park, Sil Park, Anna Kozlowska, Shuting Sun, Charles E. McKenna, Ichiro Nishimura, and Anahid Jewett
|
| 41398 |
